Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2014 16:30 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results

CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
May 01, 2014 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review

CAMBRIDGE, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
April 30, 2014 08:00 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences

CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will host a fireside chat at the Deutsche Bank Securities 39th...
April 07, 2014 07:00 ET | Source: Idenix Pharmaceuticals

Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C

Idenix Reports Positive Proof-of-Concept Data for Lead Nucleotide Prodrug, IDX21437 Idenix on Track to Initiate All-Oral Pan-Genotypic Phase II Combination Clinical Study of IDX21437 and...
March 24, 2014 08:00 ET | Source: Idenix Pharmaceuticals

Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
March 24, 2014 07:00 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case

CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
March 14, 2014 07:00 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe

CAMBRIDGE, Mass., March 14, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
February 27, 2014 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results

CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
February 26, 2014 08:00 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

CAMBRIDGE, Mass., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present at the Cowen & Company 34th Annual Health Care...
February 07, 2014 08:30 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat discussion at the 2014 Leerink...